RESUMOEste estudo objetiva estimar a prevalência de sintomas de asma e de provável asma em escolares de Uruguaiana, estado do Rio Grande do Sul, e relacioná-los com possíveis fatores de risco. Para isso, participaram do estudo 391 crianças e adolescentes nas faixas etárias de 6-7 e 13-14 anos, tanto do gênero feminino quanto masculino, cujos responsáveis preencheram corretamente o questionário ISAAC fase I aplicado durante o período de janeiro a novembro de 2015. A prevalência de asma relacionada aos sintomas e fatores de risco na população escolar de Uruguaiana foi de 15%, correspondendo 19% na faixa etária de 6-7 anos e 12% na faixa etária de 13-14 anos. Não houve relação estabelecida entre prevalência de sintomas asmáticos e fatores ambientais. Conclui-se que a prevalência de sintomas asmáticos e de provável asma é similar as outras cidades do RS.
Descritores
ABSTRACTThis study aims to estimate the prevalence of asthma symptoms and likely asthma in children of Uruguaiana, State of Rio Grande do Sul, and relate them to possible risk factors. For this, participated of the study 391 children and adolescents in the age groups 6-7 and 13-14 years, both female and male genres, whose leaders consented to the study and correctly completed the questionnaire ISAAC phase I applied during the period from March to December 2015. The prevalence of asthma and related symptoms in the school population of Uruguaiana was 15%, representing 19% aged 6-7 years and 12% aged 13-14 years. There was no relationship established between the prevalence of asthma symptoms and environmental factors. It concludes that the prevalence of asthma symptoms and likely asthma is similar to other cities in the RS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.